Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
Artiva Biotherapeutics, Inc. shareholders
As of Sep 30, 2026, 94 institutions reported holding Artiva Biotherapeutics, Inc., 83.3% of its shares. Largest: Ra Capital Management, L.P., Viking Global Investors LP and Blackstone Inc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Artiva Biotherapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 18.5M | 37.4% | +534K | Nov 16, 2026 |
| Viking Global Investors LP | 2.6M | 5.3% | no change | Nov 16, 2026 |
| Blackstone Inc. | 2.4M | 4.9% | no change | Nov 16, 2026 |
| 5AM Venture Management, LLC | 2.35M | 4.8% | no change | Nov 16, 2026 |
| Venrock Adviser, LLC | 2.04M | 4.1% | no change | Nov 16, 2026 |
| Franklin Templeton | 2.04M | 4.1% | +43,781 | Nov 12, 2026 |
| BlackRock | 1.51M | 3.1% | +817K | Nov 13, 2026 |
| Caligan Partners LP | 1.48M | 3.0% | −255K | Nov 16, 2026 |
| Vanguard | 1.36M | 2.8% | +186K | Nov 13, 2026 |
| Samsara Biocapital, LLC | 955K | 1.9% | no change | Nov 16, 2026 |